Prevalence and the impact of hypogammaglobulinemia in newly diagnosed chronic lymphocytic lymphoma patients.

Singh, Namrata; Mott, Sarah L; Sutamtewagul, Grerk; McCarthy, Ashley; Slager, Susan L; Cerhan, James R; Ballas, Zuhair; Link, Brian K

Singh, Namrata; Mott, Sarah L; Sutamtewagul, Grerk; McCarthy, Ashley; Slager, Susan L; Cerhan, James R; Ballas, Zuhair; Link, Brian K.

Afiliação

Singh N; Division of Rheumatology University of Washington Seattle Washington USA.
Mott SL; Holden Comprehensive Cancer Center (HCCC) University of Iowa Iowa City Iowa USA.
Sutamtewagul G; Holden Comprehensive Cancer Center (HCCC) University of Iowa Iowa City Iowa USA.
McCarthy A; Holden Comprehensive Cancer Center (HCCC) University of Iowa Iowa City Iowa USA.
Slager SL; Division of Allergy and Immunology University of Iowa Iowa City Iowa USA.
Cerhan JR; Holden Comprehensive Cancer Center (HCCC) University of Iowa Iowa City Iowa USA.
Ballas Z; Mayo Clinic Division of Biomedical Statistics and Informatics Rochester Minnesota USA.
Link BK; Mayo Clinic Division of Epidemiology Rochester Minnesota USA.

EJHaem ; 1(2): 537-544, 2020 Nov.

Article em En | MEDLINE | ID: mdl-35845010

Palavras-chave

IgA; IgE; chronic lymphocytic lymphoma; hypogammaglobulinemia; survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: EJHaem Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google